Causal associations and shared genetics between hypertension and COVID-19
Related Experiment Video
Updated: Aug 6, 2025

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
Ancha Baranova1,2, Hongbao Cao1, Fuquan Zhang3,4
1School of Systems Biology, George Mason University, Fairfax, Virginia, USA.
Insights
Genetically determined hypertension increases the risk for severe COVID-19. Shared genetic factors and inflammatory pathways link hypertension to increased COVID-19 hospitalization risk.
Area of Science:
- Genetics
- Epidemiology
- Molecular Biology
Background:
- Hypertension is a prevalent condition globally.
- COVID-19 has shown varied severity, with some individuals experiencing more severe outcomes.
- Understanding the interplay between hypertension and COVID-19 severity is crucial for public health.
Purpose of the Study:
- To investigate the genetic relationship between hypertension and COVID-19.
- To explore molecular pathways that may link hypertension to severe COVID-19.
- To identify shared genetic variations and causal effects.
Main Methods:
- Genetic correlation analysis was performed.
- Mendelian randomization (MR) analyses were utilized.
- Genome-wide association signals were compared to identify shared genetic loci and genes.
- Hypertension-driven molecular pathways were constructed from literature data.
Main Results:
- A positive genetic correlation (rg = 0.19) was found between hypertension and COVID-19.
- MR analyses indicated a causal effect of genetic liability to hypertension on hospitalized COVID-19 (OR: 1.05).
- Three overlapping loci and eight shared protein-coding risk genes (e.g., ABO, WNT3) were identified.
- Molecular pathway analysis suggested hypertension promotes COVID-19 via inflammatory pathways.
Conclusions:
- Genetically determined hypertension is associated with an increased risk of severe COVID-19.
- Shared genetic variations and molecular pathways, particularly inflammatory ones, may underlie the causal link.
- These findings highlight hypertension as a potential risk factor for severe COVID-19 outcomes.
Abstract:
To evaluate the genetic relationship between hypertension and COVID-19 and explore the molecular pathways linking hypertension to COVID-19. We performed genetic correlation and Mendelian randomization (MR) analyses to assess potential associations between hypertension and hospitalized COVID-19. We compared genome-wide association signals to reveal shared genetic variation between hypertension and hospitalized COVID-19. Moreover, hypertension-driven molecular pathways were constructed based on large-scale literature data to understand the influence of hypertension on COVID-19 at the molecular level. Hypertension has a positive genetic correlation with COVID-19 (rg = 0.19). The MR analyses indicate that genetic liability to hypertension confers a causal effect on hospitalized COVID-19 (odds ratio [OR]: 1.05, confidence interval [CI]: 1.00-1.09, p = 0.030). Hypertension and hospitalized COVID-19 have three overlapping loci and share eight protein-coding risk genes, including ABO, CSF2, FUT2, IZUMO1, MAMSTR, NPNT, RASIP1, and WNT3. Molecular pathway analysis suggests that hypertension may promote the development of COVID-19 through the induction of inflammatory pathways. Our study suggests that genetically determined hypertension may increase the risk for severe COVID-19. The shared genetic variation and the connecting molecular pathways may underline causal links between hypertension and COVID-19.
More Related Videos
Related Concept Videos
Hypertension II: Pathophysiology
Hypertension and Regulation of Blood Pressure
Causality in Epidemiology
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension I: Introduction

